Live Breaking News & Updates on Moleculin Biotech Inc

Stay updated with breaking news from Moleculin biotech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Short Interest in Moleculin Biotech, Inc. (NASDAQ:MBRX) Declines By 38.3%

Moleculin Biotech, Inc. (NASDAQ:MBRX – Get Free Report) saw a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 21,100 shares, a drop of 38.3% from the May 15th total of 34,200 shares. Based on an average daily volume of 40,200 shares, the days-to-cover ratio […] ....

Roth Mkm , Moleculin Biotech Inc , Exchange Commission , Atticus Wealth Management , Maxim Group , Moleculin Biotech , Get Free Report , Wealth Management , Free Report , Moleculin Biotech Daily ,

Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the stock. A number of other research analysts also recently commented on the company. Maxim Group dropped their price objective on Moleculin Biotech from $45.00 to $20.00 and set […] ....

Roth Mkm , Atticus Wealth Management , Moleculin Biotech Inc , Maxim Group , Moleculin Biotech , Free Report , Wealth Management , Get Free Report , Moleculin Biotech Daily ,

Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress

HOUSTON, May 16, 2024 /PRNewswire/ Moleculin Biotech, Inc., , a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today. ....

United States , Jenene Thomas , Wolframcm Dempke , Moleculin Biotech Inc , Prnewswire Moleculin Biotech Inc , European Chief Medical Officer , Moleculin Biotech , Transcription Modulator ,

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)

Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Jenene Thomas , Priya Kumthekar , Walter Klemp , Northwestern University Investigative New Drug , Moleculin Biotech Inc , Northwestern University , Securities Exchange , Exchange Commission , Amy Heimberger At Northwestern University , Drug Administration , National Institutes Of Health , Investigator Initiated Phase , Moleculin Biotech , Investigative New Drug , National Institutes , Associate Professor , Transcription Modulator , Amy Heimberger , Chief Executive Officer , Orphan Drug Designation , Rare Pediatric Disease , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Codon Publications ,

Soft Tissue Sarcoma Pipeline, FDA Approvals, Unmet Needs, Preclinical And Discovery Stage Product, And Companies 2024 (Updated)

Soft Tissue Sarcoma Pipeline, FDA Approvals, Unmet Needs, Preclinical And Discovery Stage Product, And Companies 2024 (Updated)
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Iovance Biotherapeutics , Lyell Immunopharma , Taiho Pharmaceuticals , Moleculin Biotech Inc , Therapeutics Inc , Novartis Pharmaceuticals Incyte Corporation , Takara Bio Inc , Advenchen Laboratories , Tissue Sarcoma Companies , Route Of Administration , Chipscreen Biosciences Ltd , Aadi Bioscience Inc , Chia Tai Tianqing Pharmaceutical Co Ltd , Tissue Sarcoma Products Development , Tissue Sarcoma Key Companies , Guangdong Xiangxue Precision Medical Technology Co Ltd , Cornerstone Pharmaceuticals , Tracon Pharmaceuticals , Sunshine Guojian Pharmaceutical Shanghai Co Ltd , Tracon Pharmaceuticals Inc , Lytix Biopharma Incyte Corporation , Telix Pharmaceuticals , Jazz Pharmaceuticals , Tissue Sarcoma Pipeline Insight , Soft Tissue Sarcoma , Soft Tissue Sarcoma Pipeline Report ,